amyotrophic-lateral-sclerosis

Documents about amyotrophic-lateral-sclerosis

• Reevaluating the role of beta2-microglobulin: new insights on selective vulnerability in ALS pathology#253621Europe PMC
• Control Cohort CTRL COH#868171ClinicalTrials.gov
• Obi Medical Robot: Evaluating Effectiveness Related to Usability#913146ClinicalTrials.gov
• NYSCF Scientific Discovery Biobank#871873ClinicalTrials.gov
• Comprehensive clinical and genetic architecture of familial amyotrophic lateral sclerosis in China: A 15-year cohort study with 302 families#246385Europe PMC
• Acute Intermittent Hypoxia and Breathing in Neuromuscular Disease#830280ClinicalTrials.gov
• A follow-on Study to Assess Long-term Safety and Tolerability of i.c.v Administration of sNN0029 in Patients With ALS#842063ClinicalTrials.gov
• Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intrathecal Injection for ALS#864776ClinicalTrials.gov
• RAPA-501 Therapy of ALS Expanded Access Protocol#881278ClinicalTrials.gov
• Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease#846330ClinicalTrials.gov
• Efficacy and safety of masitinib in amyotrophic lateral sclerosis patients prior to loss of functionality: A subgroup analysis optimizing the benefit-risk profile of masitinib#29760bioRxiv / medRxiv
• Small RNA sequencing identifies serum tDR-1:34-Gly-GCC tiRNA levels as a biomarker for survival in amyotrophic lateral sclerosis#205473Europe PMC
• TDP-43-Mediated Toxicity in HEK293T Cells: A Fast and Reproducible Protocol To Be Employed in the Search of New Therapeutic Options against Amyotrophic Lateral Sclerosis#384791HAL (France)
• Dysregulations of Expression of Genes of the Ubiquitin/SUMO Pathways in an In Vitro Model of Amyotrophic Lateral Sclerosis Combining Oxidative Stress and SOD1 Gene Mutation#384799HAL (France)
• Cellular Logistics and Synaptic Vesicle Vulnerability in Major Depressive Disorder and Amyotrophic Lateral Sclerosis Comorbidity: Insights From Nicotinamide Mononucleotide Rescue and Transcriptome-Wide Association Study Integration.#415480NCBI PubMed Central
• Intraspinal Transplantation of Autologous ADRC in ALS Patients#918794ClinicalTrials.gov
• What do ALS motor phenotypes measure? A population-based decomposition of their prognostic dimensions#1038719Europe PMC
• Behavioral, Hormonal, Inflammatory, and Metabolic Effects Associated with FGF21-Pathway Activation in an ALS Mouse Model#202532HAL (France)
• Proteomic profile of CSF obtained at the time of diagnosis determines amyotrophic lateral sclerosis progression and survival: CXCL7 levels in disease prognosis and survival.#422898NCBI PubMed Central
• Chapter Genetics of Amyotrophic Lateral Sclerosis#433072DOAB PROD Instance
• Chromatic Pupillometry to Assess the Melanopsin-Light Pathway in Progressive Supranuclear Palsy#803648ClinicalTrials.gov
• HEALEY ALS Platform Trial - Regimen G DNL343#805739ClinicalTrials.gov
• 7T Imaging Pilot-study in Patients With Motor Neuron Disease to Find Non-Invasive Disease Imaging Biomarkers#918612ClinicalTrials.gov
• Pharmacological modulation with the LXR agonist T0901317 attenuates motor pathology in the SOD1G93A mouse model of ALS#922282Europe PMC
• Gut-Brain Axis Deregulation and Its Possible Contribution to Neurodegenerative Disorders#948841Repositorio de Universidad Autónoma de Chile.
• La evolución del cuidado enfermero en un paciente con ELA. Basado en el modelo de Dorothea Orem#396870Repositorio Institucional de la Universidad de Burgos (RIUBU)
• Quantification of Hsp90 in the Human Brain#849529ClinicalTrials.gov
• Exploiting ROS and metabolic differences to kill cisplatin resistant lung cancer#955036Koc University Digital Collections
• Exploring the Lived Experiences of Individuals with Amyotrophic Lateral Sclerosis (ALS): A Qualitative Study and Conceptual Model of Signs, Symptoms, and Functional Impacts#180534Springer Nature OA
• Delivering effective non-invasive ventilation in amyotrophic lateral sclerosis using intensive remote support (DENIM): protocol for an embedded process evaluation in a hybrid type 3 implementation-effectiveness trial.#645253NCBI PubMed Central
• HEALEY ALS Platform Trial - Regimen C CNM-Au8#848730ClinicalTrials.gov
• Neurobiological and Immunological Mechanisms of Dyspnea in ALS (BIOPNEA)#896588ClinicalTrials.gov
• Cognitive and Behavioural Profile of SOD1-ALS Across the ALS-FTD Spectrum: A Systematic Review#923139IRIS
• MND Together: Phase 1#993098ClinicalTrials.gov
• Connect-One: Early Feasibility Study of Connexus® Brain-Computer Interface (BCI)#1030885ClinicalTrials.gov
• Therapeutic frontiers in ALS: iPSC-based drug discovery, cell therapy, and gene therapy-Advances through 2026#353872Europe PMC
• Familial, neuropathological and cellular analysis identify ARPP21 as a major amyotrophic lateral sclerosis associated gene in French cohorts#780647Europe PMC
• Confirmation of Self-Reported Incident ALS Cases in the AARP-Diet and Health (AARP-DH) Cohort#810175ClinicalTrials.gov
• A Safety and Biomarker Study of ALZT-OP1a in Subjects With Mild-Moderate ALS Disease#837162ClinicalTrials.gov
• Relationship Between Respiratory Functional Tests and Image Thoracic Techniques in Patients With Neuromuscular Diseases#854419ClinicalTrials.gov
• ALS and Airway Clearance (ALSAC) Therapy#900972ClinicalTrials.gov
• Assessment of social cognition in patients with amyotrophic lateral sclerosis: protocol for a cross-sectional comparative study at Angers University Hospital#147643HAL (France)
• Research on Wireless Brain Implant System for General Control of External Devices#969040ClinicalTrials.gov
• Kinetics and Spatial Distribution of β-Sheet Development in TDP-43<sub>CTD</sub> Condensate Maturation#266537Europe PMC
• Frontotemporal Lobar Degeneration‐TDP Type C With Striatal Glial Cytoplasmic Inclusions and Motor Neuron Degeneration#453057OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Respiratory Care in Intensive Care Unit for Neuromuscular Patients#829260ClinicalTrials.gov
• Proteinopathies Expression in Skin of Neurodegenerative Disorders#835436ClinicalTrials.gov
• Omics Sciences for the Identification of Pathogenetic Mechanisms and Biomarkers in Neurodegenerative Diseases#900988ClinicalTrials.gov
• Auto-calibrating System for Upper Limb Disability Assessment, Neurological and Occupational Rehabilitation#903804ClinicalTrials.gov
• Ceramide and Sphingosine-1-Phosphate in Neurodegenerative Disorders and Their Potential Involvement in Therapy#360093IRIS